{"name":"Senseonics Holdings Inc.","slug":"senseonics","ticker":"SENS","exchange":"NYSE American","domain":"senseonics.com","description":"Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.","hq":"Germantown, MD","founded":0,"employees":"130","ceo":"Tim Goodnow, PhD","sector":"MedTech / Diabetes","stockPrice":5.87,"stockChange":0.37,"stockChangePercent":6.73,"marketCap":"$306M","metrics":{"revenue":40711000,"revenueGrowth":87.2,"grossMargin":52.1,"rdSpend":0,"netIncome":-87187000,"cash":64321000,"dividendYield":0,"peRatio":-2.6,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-08-09","type":"earnings","headline":"Senseonics Reports Second Quarter 2024 Financial Results","summary":"Senseonics Holdings, Inc. (SENS) today reported financial results for the second quarter ended June 30, 2024.","drugName":"","sentiment":"neutral"},{"date":"2024-05-23","type":"deal","headline":"Senseonics Announces Collaboration with Medtronic to Develop Next-Generation CGM System","summary":"Senseonics Holdings, Inc. (SENS) today announced a collaboration with Medtronic to develop a next-generation continuous glucose monitoring (CGM) system.","drugName":"","sentiment":"positive"},{"date":"2023-11-14","type":"regulatory","headline":"Senseonics Receives FDA Clearance for Eversense 90-Day CGM System","summary":"Senseonics Holdings, Inc. (SENS) today announced that it has received FDA clearance for its Eversense 90-Day CGM System.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxOSW4zUzM2V1NQU1Rsa21nNEZIdm95RV9XcU1QdXU4SEcwTkx2dnh1bnJUdW9LYkJKV3E0NTJwNEpENTNWd2ZZdHl5LVh4V2Ywem1OVHZUSGY4ay1reEpuNzc2R2hkb2lmOFluUFhZU0IySXo0Y0FSVlRMVUxObUJwdXpHMWJiTklqeUFNS3dYZTVXNnlDNGFTakZ6OVdfT3lIa3JITFJ4OWtITjMtUWt6LWhxZmVnNjF1eWJxR1NLdVFoNTBZM2I4NnNySnY?oc=5","date":"2026-03-16","type":"pipeline","source":"MarketBeat","summary":"Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) CEO Purchases $99,732.75 in Stock - MarketBeat","headline":"Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) CEO Purchases $99,732.75 in Stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPWXpwTlVqdVB0X2YyVE1LN0Y2ZGotTXNpdUpiR3BMRVNZcGs3N1NqclEyLU90VC1tbFpHREh5cG9VTmUtQkxNU2RqcGdySGpjQ0JZSWM5YWFpZ29xbDhHQldLajFfdG8tc2tWOEQwVWphdDhtQXhlcTJ6Z3IxenNsRFJuYUVjWEdyZWxaZmliYmVxQkhPMGFsMXVfcDZKVDFwS1BfbFJnaS1XWjRsV2JWVzZCZmgwSmxWUlJaQw?oc=5","date":"2026-03-02","type":"pipeline","source":"Stock Titan","summary":"Diabetes implant sees 103% jump in new patients at Senseonics - Stock Titan","headline":"Diabetes implant sees 103% jump in new patients at Senseonics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNSkdGTFZXWlFIVGZsaDc3azZ5MmFGd0pXVU9HMlFDaEJaT0JwcVJhQkJ5SGVCc01fXzZZS0RLS3JSdTB1ZWpmQ1pfVGdEa01JclJuWFRwbTdkS1U0TXpoWVlBdG5HVEtfMFBFalI2bHNBMlJ1M3dLLTZ4VVdhZHVKRUE2Y1pWVy1wSWhLbFRtUXllbzczYVNWNzZVcmJOaXk2cmY5ZW1OVnN1QnRhclc4a1FB?oc=5","date":"2026-03-02","type":"earnings","source":"Stock Titan","summary":"Senseonics (SENS) posts 2025 growth and projects 65–76% higher 2026 revenue - Stock Titan","headline":"Senseonics (SENS) posts 2025 growth and projects 65–76% higher 2026 revenue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxObTk4ZGJMZGY0ZHFsLUV0OHpYX3B6UEVaVnVOeGdkU2Z6X0NFa01qdFNqbGhvd1RYUEd2R19YY3JHZEZFdXVrQkVRcnNVQU54MURveUlwN0xGVVBIQzFTZjdoVEF3aFhMdnEySzVRTWpMaFBuUl9jMUk5MkU0M3d2VWx6UzR6NjZtLVNVRERXYlNUZnFyV2ZhajN5Vlk3Y0xBb184VnRqakRtS0NQdEZfRUxLRTl5OGVVQXBVTC03bUJCQUtFeEczVUROeXpHVUp6Q1FUb180VGxkVy12Y0hPTTl6SEp1TEZJZUFSZTNfOHFTNnNZWDVhbDJtSFZOLWkzTVQ3SnRnVDVTNzROa3VGczlPTnh1clpt?oc=5","date":"2026-02-21","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Senseonics Holdings (SENS) and Novo Nordisk (NVO) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Senseonics Holdings (SENS) and Novo Nordisk (NVO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPaEpZZzY5MzFHVHRHZHc2bEk2VEx1S2pCSG1MYlAtbzhraTlLS1lJOHkya2lfX1VmeG04YlVHb29WVnpHMUhnSm5hNlAydnVQLWpZZFF5elBvWFNCZ19qVmVrYlAtRXVWLVVMd1hDVFR3b3lKalF2Wl9pYkNvUjQ5Njl0VXBnWHRZcnd0UWZzbTd5aDc2VEFRTy1hYXZ6cE9jbElJNmEyUDZ6YWRlRkNmbC04cFBnVkJScGJnRGwzUEI?oc=5","date":"2025-11-10","type":"pipeline","source":"Stock Titan","summary":"Senseonics (NYSE American: SENS) sets Stifel fireside chat for 4:40 p.m. ET on Nov. 12 - Stock Titan","headline":"Senseonics (NYSE American: SENS) sets Stifel fireside chat for 4:40 p.m. ET on Nov. 12","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOcUYweWRIUEtlWGRRdnJUdnE3TGRuNWdLazRhTVhqMTM2cTJnanhxQkhWd0t6bERzZExLTlNaY0M1RVEzQW16RVN2d2w1SFFuN2lNY0E1bVZIUjd2djdNZW5sMDIxTzNFRHpuNXJ2Qmk1UHM5WklFZ2ZSNlFSWHMwU3JpaEJsZnZvd29PRk93?oc=5","date":"2025-11-06","type":"pipeline","source":"Seeking Alpha","summary":"Senseonics down as 2025 guidance trails consensus - Seeking Alpha","headline":"Senseonics down as 2025 guidance trails consensus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQOFpKRE5ab3BTOTMxQ0JxU21UX1gwQjAxaVl0U3RaQkd5RFFOc1ZSdWpCYnp4cXlIckQ0VjFKeVBZQkhjamZEa2Nic0x0SDNHeXVTVGs4azlKZmRmanJCSENvX0hWRlBNcHhpWVVHeVotYl9BandnZUJ4RkxpdzZ0NUdGUGtreG5zNllRWUZXNlNnV3o2ak9aaFpXeFlmRnBjUTNCN2MzMjFTdUt4UGlpNFhENzdoWnc?oc=5","date":"2025-10-22","type":"earnings","source":"Stock Titan","summary":"Senseonics (NYSE American: SENS) sets Nov 5 third quarter 2025 results release, call - Stock Titan","headline":"Senseonics (NYSE American: SENS) sets Nov 5 third quarter 2025 results release, call","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQbFNNQ2ZqRzd1c3pRRGZ6d2daRDBldnZCR3U5azEyUGN0Nzc4d1BYa1ZkR01kLXlkUlcwM2FDMXNRb1g3MmowanlQZnFQdS02djBubVFaV2wycmlYU2wxR01jY01sdUFnaC1DSU5PTFJWQnVRUFQ5X1cxX2s4Y3J0ZzVFVmgwQ21TQjJPS28ycGFkNVBYME9fYjN2ZG5oNUNfQU50ajZPc1g0bWRXSVNyVTVXSjFGcm5mTTNDUHZXTmo?oc=5","date":"2025-10-06","type":"earnings","source":"Stock Titan","summary":"$8.1M Q3 2025 Revenue — Senseonics Sees 160% U.S. New Patient Growth; 1:20 Reverse Split Oct 17 - Stock Titan","headline":"$8.1M Q3 2025 Revenue — Senseonics Sees 160% U.S. New Patient Growth; 1:20 Reverse Split Oct 17","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOaW5OT0VweXBCcG0tS2RFelZRNnM4akJoMC1pU1NUT0JrMi1OaDVvNnVqSkhWNnRVbjNjaFdqS3lUZk9PUE51V2hkTDZyNGlOaUVxT19Wa3FSeVNhVjVvQnowOXJJTE1kVld0UFQtRDBtU1ZjaTM1cXFhQU5UWjBwZnE4TW5vdUdwX1dRZUE3Mm5Tc3VFam9KMGY2Zlpwa2pIRmpJWGZpQWlySlhCS25uS2RlMjdtYVRBM0hSSw?oc=5","date":"2025-05-21","type":"pipeline","source":"Seeking Alpha","summary":"Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity (NYSE:SENS) - Seeking Alpha","headline":"Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity (NYSE:SENS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxONjMxQmQydUgzNUo2OEVZN0l4WWNHWFh0bEphNUhxTGV4VmRQazZNVXU3WVZ4cDJZWGtCRHpXQV81LVZGRmJzbmxucDhRVVlKYmotVVBWMWpGTEF3M1RTbDJLUFRpUDBEUGZ6b0IzUzNjeVk4ZXNBaHZLa1diMEtFbXp4aGg2V09Od3dUdThrZmJ3SHFob1ZKWDZLaW5nVEdjWWpyV1VEYzZzc0hfZjV0ZlFMcHZoUU1wZHJ0VGlPRTRERXQ2WjlFOGJR?oc=5","date":"2025-01-19","type":"pipeline","source":"Seeking Alpha","summary":"Senseonics Holdings' Metrics Potentially Highlight Launch-Driven Growth, Not Sustainability - Seeking Alpha","headline":"Senseonics Holdings' Metrics Potentially Highlight Launch-Driven Growth, Not Sustainability","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNclB0VlVMX19oekVpbTNIWm4xLVBGLUVmczFtSmRNSlpQSUVVcXVVUDctYm5rMUFVVFkySFExYy1QZXlKX3E1ZnJWRjRheGM4YTIycEpGY3FIb3hXUkV2ZkFEMEdWTmlMU1NSamx1WmVTWDJ6RWdocTBETG55YkJxS1BQU1g?oc=5","date":"2025-01-06","type":"deal","source":"Yahoo Finance","summary":"Here’s Why Senseonics Holdings, Inc. (NYSE:SENS) Is Among the Best Diabetes Stocks to Buy Under $10 - Yahoo Finance","headline":"Here’s Why Senseonics Holdings, Inc. (NYSE:SENS) Is Among the Best Diabetes Stocks to Buy Under $10","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE82UVNIbGdjcU1IZG5NckI4aFJEeHZOQVJ1Qy0xWlktcnU2VEdZNGxaN1NSSk1mY0ZYNlNyRGZOb2dUeElobTdpYzIyMERobHVCc0FmdHZhNG53dDc4TUZ4dVA0QndmM1RaNXVrY3A3ZmUxV09DUjFnZ2Q1X0U?oc=5","date":"2021-07-14","type":"deal","source":"InvestorPlace","summary":"7 Robinhood Stocks To Buy For Under $5 - InvestorPlace","headline":"7 Robinhood Stocks To Buy For Under $5","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Medtronic","Dexcom","Abbott Laboratories"],"therapeuticFocus":["Diabetes Management"],"financials":{"source":"yahoo_finance","revenue":35257000,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":35257000},{"period":"2024-12-31","value":22472000},{"period":"2023-12-31","value":22390000},{"period":"2022-12-31","value":16389000}],"grossProfit":15763000,"grossProfitHistory":[{"period":"2025-12-31","value":15763000},{"period":"2024-12-31","value":533000},{"period":"2023-12-31","value":3091000},{"period":"2022-12-31","value":2726000}],"rdSpend":31592000,"rdSpendHistory":[{"period":"2025-12-31","value":31592000},{"period":"2024-12-31","value":41144000},{"period":"2023-12-31","value":48752000},{"period":"2022-12-31","value":39719000}],"sgaSpend":52508000,"operatingIncome":-68337000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-68337000},{"period":"2024-12-31","value":-74842000},{"period":"2023-12-31","value":-75603000},{"period":"2022-12-31","value":-68627000}],"netIncome":-69113000,"netIncomeHistory":[{"period":"2025-12-31","value":-69113000},{"period":"2024-12-31","value":-78616000},{"period":"2023-12-31","value":-60392000},{"period":"2022-12-31","value":142119000}],"eps":-2.5,"epsHistory":[{"period":"2024-12-31","value":-2.5},{"period":"2023-12-31","value":-0.11},{"period":"2022-12-31","value":-0.11},{"period":"2021-12-31","value":-0.72}],"cash":40234000,"cashHistory":[{"period":"2025-12-31","value":40234000},{"period":"2024-12-31","value":74597000},{"period":"2023-12-31","value":75709000},{"period":"2022-12-31","value":35793000}],"totalAssets":126269000,"totalLiabilities":65223000,"totalDebt":41371000,"equity":61046000,"operatingCashflow":-59129000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-59129000},{"period":"2024-12-31","value":-60465000},{"period":"2023-12-31","value":-70163000},{"period":"2022-12-31","value":-66312000}],"capex":-1116000,"capexHistory":[{"period":"2025-12-31","value":-1116000},{"period":"2024-12-31","value":-2239000},{"period":"2023-12-31","value":-350000},{"period":"2022-12-31","value":-312000}],"freeCashflow":-60245000,"dividendsPaid":null,"buybacks":null,"employees":130,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":19775000,"ebit":-19617000,"ebitda":-19235000,"period":"2025-12-31","revenue":14256000,"epsBasic":null,"netIncome":-20823000,"rdExpense":8819000,"epsDiluted":null,"grossProfit":7669000,"operatingIncome":-20925000},{"sga":15310000,"ebit":-18359000,"ebitda":-17983000,"period":"2025-09-30","revenue":8095000,"epsBasic":-0.43,"netIncome":-19530000,"rdExpense":7759000,"epsDiluted":-0.43,"grossProfit":3468000,"operatingIncome":-19601000},{"sga":9729000,"ebit":-13356000,"ebitda":-12986000,"period":"2025-06-30","revenue":6649000,"epsBasic":-0.02,"netIncome":-14501000,"rdExpense":7715000,"epsDiluted":-0.02,"grossProfit":3121000,"operatingIncome":-14323000},{"sga":7694000,"ebit":-12830000,"ebitda":-12446000,"period":"2025-03-31","revenue":6257000,"epsBasic":-0.02,"netIncome":-14259000,"rdExpense":7299000,"epsDiluted":-0.02,"grossProfit":1505000,"operatingIncome":-13488000},{"sga":8862000,"ebit":-13305000,"ebitda":-12539000,"period":"2024-12-31","revenue":8297000,"epsBasic":null,"netIncome":-15476000,"rdExpense":9360000,"epsDiluted":null,"grossProfit":3951000,"operatingIncome":-14271000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":-0.8,"netIncome":null,"rdExpense":null,"epsDiluted":-0.8,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":5.87,"previousClose":5.5,"fiftyTwoWeekHigh":12.58,"fiftyTwoWeekLow":4.79,"fiftyTwoWeekRange":"4.79 - 12.58","fiftyDayAverage":6.34,"twoHundredDayAverage":7.42,"beta":0,"enterpriseValue":207751056,"forwardPE":-2.6,"priceToBook":7.14,"priceToSales":7.53,"enterpriseToRevenue":5.1,"enterpriseToEbitda":-2.44,"pegRatio":0,"ebitda":-85189000,"ebitdaMargin":-209.3,"freeCashflow":0,"operatingCashflow":0,"totalDebt":42197000,"debtToEquity":122.9,"currentRatio":3.5,"returnOnAssets":-57,"returnOnEquity":-250.8,"analystRating":"2.0 - Buy","recommendationKey":"buy","numberOfAnalysts":6,"targetMeanPrice":17.42,"targetHighPrice":31,"targetLowPrice":8,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":9.6,"institutionHeldPercent":16.2,"sharesOutstanding":52202965,"floatShares":38506163,"sharesShort":5246497,"shortRatio":17.26,"shortPercentOfFloat":12.6,"epsTrailing":-1.97,"epsForward":-2.27,"revenuePerShare":0.92,"bookValue":0.82,"officers":[{"age":63,"name":"Dr. Timothy T. Goodnow Ph.D.","title":"President, CEO & Director"},{"age":43,"name":"Mr. Frederick T. Sullivan CPA","title":"CFO, Secretary & Treasurer"},{"age":52,"name":"Dr. Mukul  Jain Ph.D.","title":"Chief Operating Officer"},{"age":74,"name":"Dr. Francine Ratner Kaufman M.D.","title":"Chief Medical Officer & Director"},{"age":57,"name":"Mr. Brian B. Hansen","title":"Chief Commercial Officer & Director"},{"age":58,"name":"Mr. Kenneth L. Horton J.D.","title":"General Counsel & Corporate Development Advisor"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.senseonics.com","phone":"301 515 7260"}}